Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Fate therapeutics, inc. save search
Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-03 (Crawled : 19:00) - biospace.com/
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: -0.29%
H: 7.52%
C: 3.39%
conference therapeutics
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-02 (Crawled : 20:00) - globenewswire.com
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: -0.29%
H: 7.52%
C: 3.39%
award nasdaq therapeutics employee
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
Published: 2024-03-19 (Crawled : 12:30) - globenewswire.com
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: -2.98%
H: 6.59%
C: 2.49%
million offering therapeutics
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-05 (Crawled : 21:00) - globenewswire.com
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: 3.32%
H: 12.71%
C: 11.45%
award nasdaq therapeutics employee
Fate Therapeutics to Present at Upcoming March Investor Conferences
Published: 2024-03-01 (Crawled : 13:00) - globenewswire.com
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: 0.99%
H: 8.94%
C: 8.1%
therapeutics
Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
Published: 2024-02-26 (Crawled : 21:00) - globenewswire.com
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: 8.78%
H: 14.15%
C: -1.32%
business year therapeutics financial results
Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-15 (Crawled : 13:00) - globenewswire.com
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: 2.16%
H: 8.6%
C: 6.79%
conference year therapeutics financial results
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-02-02 (Crawled : 21:00) - globenewswire.com
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
| Email alert
Add to watchlist
nasdaq awards therapeutics employee
Fate Therapeutics Announces Initiation of Phase 1 Clinical Trial for FT825 / ONO-8250 in Patients with HER2-expressing Advanced Solid Tumors
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: 0.8%
H: 13.16%
C: 8.42%
ft825 tumors trial therapeutics advanced
Fate Therapeutics Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-12-13 (Crawled : 22:00) - globenewswire.com
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: 5.22%
H: 7.09%
C: 5.67%
nasdaq grants therapeutics employee
Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2023 Financial Results
Published: 2023-10-25 (Crawled : 12:00) - globenewswire.com
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: 0.52%
H: 1.03%
C: -7.69%
conference therapeutics financial results
SHORELINE BIOSCIENCES WINS A COMPREHENSIVE SUMMARY JUDGEMENT VICTORY ON ALL CLAIMS BROUGHT BY FATE THERAPEUTICS AND WHITEHEAD INSTITUTE ON IPSC GENERATION AND USE
Published: 2023-09-07 (Crawled : 12:00) - prnewswire.com
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: -1.92%
H: 0.39%
C: -3.14%
institute therapeutics
Fate Therapeutics to Present at Upcoming September Investor Conferences
Published: 2023-08-31 (Crawled : 12:00) - globenewswire.com
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: 0.0%
H: 0.76%
C: -4.92%
therapeutics
Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2023 Financial Results
Published: 2023-07-28 (Crawled : 12:00) - globenewswire.com
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: 2.44%
H: 2.62%
C: 0.24%
conference therapeutics financial results
Fate Therapeutics to Present at Upcoming June Investor Conferences
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: 0.0%
H: 6.25%
C: 1.81%
therapeutics
Fate Therapeutics Reports First Quarter 2023 Financial Results and Business Updates
Published: 2023-05-03 (Crawled : 20:00) - globenewswire.com
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: -5.06%
H: 10.0%
C: 2.83%
business therapeutics financial results
Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2023 Financial Results
Published: 2023-04-24 (Crawled : 13:00) - biospace.com/
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: 2.25%
H: 0.63%
C: -0.31%
conference therapeutics financial results
FATE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 22, 2023 in the Class Action Filed on Behalf of Fate Therapeutics, Inc. Shareholders
Published: 2023-03-21 (Crawled : 10:00) - prnewswire.com
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
|
| O: 0.9%
H: 0.0%
C: -3.39%
deadline
HSAI INVESTOR NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Hesai Group Investors to Inquire About Securities Class Action Investigation - HSAI
Published: 2023-03-18 (Crawled : 00:20) - prnewswire.com
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
| Email alert
Add to watchlist
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
| Email alert
Add to watchlist
HSAI | $4.28 -0.58% -0.58% 280K
|
n/a
| Email alert
Add to watchlist
trusted group
GOOG, GOOGL EQUITY ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Alphabet Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GOOG, GOOGL
Published: 2023-03-18 (Crawled : 00:20) - prnewswire.com
FATE | $5.04 -4.36% -4.56% 2.3M
|
Health Technology
| Email alert
Add to watchlist
GOOG | News S | $157.49 0.39% 0.39% 14M
|
Technology Services
| Email alert
Add to watchlist
GOOGL | News S | $155.97 0.32% 0.32% 19M
|
Technology Services
| Email alert
Add to watchlist
HSAI | $4.28 -0.58% -0.58% 280K
|
n/a
| Email alert
Add to watchlist
deadline trial
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.